ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
An Old BP Drug for Type 1 Diabetes Control?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 99127" data-attributes="member: 2624"><p>A drug commonly used to control high blood pressure for over 50 years may also help prevent the onset of Type 1 diabetes in up to 60 percent of those at risk for the disease. <strong>Methyldopa (commonly sold under the name Aldomet) </strong>is one of the preferred drugs for controlling hypertension in pregnancy. </p><p></p><ul> <li data-xf-list-type="ul">Some 60 percent of people at risk of getting Type 1 diabetes possess a molecule known as DQ8, which significantly increases the chance of getting the disease. Researchers at the University of Colorado and the University of Florida believed that if they could block specifically the DQ8 molecule they could also block the onset of diabetes.</li> <li data-xf-list-type="ul">“We took every FDA-approved small molecule drug and analyzed HLA-DQ8 binding through a supercomputer. We searched a thousand orientations for each drug to identify those that would fit within the DQ8 molecule binding groove.”</li> </ul><p></p><p>After running thousands of drugs through the supercomputer, they found that methyldopa not only blocked DQ8, but it didn’t harm the immune function of other cells like many immunosuppressant drugs do. The research spanned 10 years and its efficacy was shown in mice and in 20 Type 1 diabetes patients who took part in a clinical trial at the Barbara Davis Center at the University of Colorado School of Medicine.</p><p></p><p></p><p>“We can now predict with almost 100 percent accuracy who is likely to get Type 1 diabetes, the goal with this drug is to delay or prevent the onset of the disease among those at risk. With this drug, we can potentially prevent up to 60 percent of Type 1 diabetes in those at risk for the disease.” </p><p></p><p>"Existing Drug Effective at Preventing Onset of Type 1 Diabetes," <em>Drug Discovery and Development, 20 February 2018, <a href="https://www.dddmag.com/news/2018/02/existing-drug-effective-preventing-onset-type-1-diabetes" target="_blank">https://www.dddmag.com/news/2018/02/existing-drug-effective-preventing-onset-type-1-diabetes</a></em></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 99127, member: 2624"] A drug commonly used to control high blood pressure for over 50 years may also help prevent the onset of Type 1 diabetes in up to 60 percent of those at risk for the disease. [B]Methyldopa (commonly sold under the name Aldomet) [/B]is one of the preferred drugs for controlling hypertension in pregnancy. [LIST] [*]Some 60 percent of people at risk of getting Type 1 diabetes possess a molecule known as DQ8, which significantly increases the chance of getting the disease. Researchers at the University of Colorado and the University of Florida believed that if they could block specifically the DQ8 molecule they could also block the onset of diabetes. [*]“We took every FDA-approved small molecule drug and analyzed HLA-DQ8 binding through a supercomputer. We searched a thousand orientations for each drug to identify those that would fit within the DQ8 molecule binding groove.” [/LIST] After running thousands of drugs through the supercomputer, they found that methyldopa not only blocked DQ8, but it didn’t harm the immune function of other cells like many immunosuppressant drugs do. The research spanned 10 years and its efficacy was shown in mice and in 20 Type 1 diabetes patients who took part in a clinical trial at the Barbara Davis Center at the University of Colorado School of Medicine. “We can now predict with almost 100 percent accuracy who is likely to get Type 1 diabetes, the goal with this drug is to delay or prevent the onset of the disease among those at risk. With this drug, we can potentially prevent up to 60 percent of Type 1 diabetes in those at risk for the disease.” "Existing Drug Effective at Preventing Onset of Type 1 Diabetes," [I]Drug Discovery and Development, 20 February 2018, [URL]https://www.dddmag.com/news/2018/02/existing-drug-effective-preventing-onset-type-1-diabetes[/URL][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
An Old BP Drug for Type 1 Diabetes Control?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top